Table 3.
Cox multivariate regression analyses for the influence of preoperative serum prealbumin on OS in overall 532 resected ESCC patients without postoperative adjuvant radiotherapy or chemotherapy
| Variables | Hazard Ratio | P | 95% CI |
|---|---|---|---|
| Overall survival | |||
| Gender(f vs m) | 0.841 | 0.255 | 0.624–1.133 |
| Age (≤60 vs >60) | 0.985 | 0.905 | 0.771–1.255 |
| Location(baseline, Proximal esophagus) | 0.099 | ||
| Mid esophagus | 0.618 | 0.057 | 0.377–1.108 |
| Distal esophagus | 0.562 | 0.032 | 0.335–0.958 |
| T stage | 2.014 | <0.001 | 1.530–2.651 |
| N stage | 2.311 | <0.001 | 1.753–3.046 |
| Differentiation(baseline, Well) | 0.002 | ||
| Moderately | 4.148 | 0.005 | 1.525–11.280 |
| Poorly | 5.252 | 0.001 | 1.925–14.328 |
| Prealbumin (baseline, high) | 0.005 | ||
| low | 1.844 | 0.001 | 1.264–2.690 |
| median | 1.315 | 0.044 | 1.007–1.716 |
| Albumin(low vs high) | 0.697 | 0.020 | 0.514–0.945 |
Abbreviations: ESCC, esophageal squamous cell carcinoma; OS, overall survival; CI, confidence interval.